Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Krystal Biotech Logo
Krystal Biotech Growth Score
70
CB Rank
41005
Heat Score
61
Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..
Founded
obfuscation
PublicPost-IPO Equity Pittsburgh, Pennsylvania, United States251-500 www.krystalbio.com/
Biopharma
Biotechnology
Health Care
Overview

Krystal Biotech
Total Funding
obfuscation
Growth Score
70
Heat Score
61

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score70
-25 pts
in past quarter
Heat Score 61
4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Krystal Biotech

CB Rank
41005
Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..
Founded
obfuscation
PublicPost-IPO Equity Pittsburgh, Pennsylvania, United States251-500 www.krystalbio.com/
Biopharma
Biotechnology
Health Care

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

  • Photo of Suma Krishnan
    Suma Krishnan: Founder & Chief Operating Officer
    Past Role: Pinnacle Pharmaceuticals, Senior Vice President of Product Development
  • Photo of Chris Mason
    Chris Mason: Director & Board Of Directors
    Past Role: University College London (UCL), Professor of Regenerative Medicine Bioprocessing

Details

Legal Name Krystal Biotech, Inc.
Operating Status Active
Stock Symbol  NASDAQ:KRYS
Company Type For Profit
Founders  Suma Krishnan
About the Company
Krystal Biotech is a biopharmaceutical company using gene therapy to develop best in class treatments that provide significant clinical benefit for patients suffering from rare debilitating disorders.
Phone Number +1 412-586-5830
Contact Email inquiries@krystalbio.com
Predictions & Insights

Growth Insight

See this Growth Insight
Krystal Biotech is
Lorem
 to be growing
Top Contributing Factors
Financial Growth

Products & Services

VYJUVEK
A redosable gene therapy for treating dystrophic epidermolysis bullosa by delivering functional COL7A1 genes to skin cells.
KB103
A topical gene therapy candidate for dystrophic epidermolysis bullosa using a replication-defective HSV-1 vector to deliver COL7A1 genes to skin cells.

Research & Development

Krystal Biotech is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Krystal Biotech Logo
Post-IPO Equity - Krystal Biotech
4
obfuscation
Avoro Capital Advisors, Redmile GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Krystal Biotech Logo
Post-IPO Equity - Krystal Biotech
4
obfuscation
Avoro Capital Advisors, Redmile GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Krystal Biotech Logo
Post-IPO Equity - Krystal Biotech
4
obfuscation
Avoro Capital Advisors, Redmile GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Krystal Biotech Logo
Post-IPO Equity - Krystal Biotech
4
obfuscation
Avoro Capital Advisors, Redmile GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Krystal Biotech Logo
Post-IPO Equity - Krystal Biotech
4
obfuscation
Avoro Capital Advisors, Redmile GroupPost-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Krystal Biotech Logo
Post-IPO Equity - Krystal Biotech
4
obfuscation
Avoro Capital Advisors, Redmile GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Krystal Biotech Logo
Post-IPO Equity - Krystal Biotech
4
obfuscation
Avoro Capital Advisors, Redmile GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Krystal Biotech Logo
Post-IPO Equity - Krystal Biotech
4
obfuscation
Avoro Capital Advisors, Redmile GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Krystal Biotech Logo
Post-IPO Equity - Krystal Biotech
4
obfuscation
Avoro Capital Advisors, Redmile GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Krystal Biotech Logo
Post-IPO Equity - Krystal Biotech
4
obfuscation
Avoro Capital Advisors, Redmile GroupPost-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Avoro Capital Advisors Logo
Avoro Capital Advisors
Yes
Post-IPO Equity - Krystal Biotech Logo
Post-IPO Equity - Krystal Biotech
—
Avoro Capital Advisors Logo
Avoro Capital Advisors
Yes
Post-IPO Equity - Krystal Biotech Logo
Post-IPO Equity - Krystal Biotech
—
Avoro Capital Advisors Logo
Avoro Capital Advisors
Yes
Post-IPO Equity - Krystal Biotech Logo
Post-IPO Equity - Krystal Biotech
—
Avoro Capital Advisors Logo
Avoro Capital Advisors
Yes
Post-IPO Equity - Krystal Biotech Logo
Post-IPO Equity - Krystal Biotech
—
Avoro Capital Advisors Logo
Avoro Capital Advisors
Yes
Post-IPO Equity - Krystal Biotech Logo
Post-IPO Equity - Krystal Biotech
—
Market Intelligence
People
View Profiles & Contacts
Headcount 251-500 Employee Profiles 5 Board Members and Advisors 1 Contacts 196

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 21, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

20,248
156.56%
 in past month

IT Spend

$7.8MThis year, Krystal Biotech is projected to spend $7.8M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Divestment Logo
Divestment
100
Data Visualization Logo
Data Visualization
100
Forecast Value-Add Logo
Forecast Value-Add
100

Actively Used Products

14Krystal Biotech uses 14 technology products and services including HTML5, Google Fonts, and  Vimeo, according to G2 Stack.

Active Website Tech Count

24Krystal Biotech is actively using 24 technologies for its website, according to BuiltWith. These include DNSSEC, IPv6, and  Amazon.

Total IP

46The intellectual property of Krystal Biotech includes 29 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Krystal Biotech has registered 17 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Krystal Biotech's headquarters? Krystal Biotech is located in Pittsburgh, Pennsylvania, United States.Who invested in Krystal Biotech? Krystal Biotech has 6 investors including Avoro Capital Advisors and  Redmile Group.When was the last funding round for Krystal Biotech? Krystal Biotech closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Krystal Biotech's competitors? Alternatives and possible competitors to Krystal Biotech may include ReCode Therapeutics, AIRNA, and  4D Molecular Therapeutics.How much funding has Krystal Biotech raised to date? Krystal Biotech has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(790e229 1)
|